Mitchell Young Williams Acquires 51,511 Shares of Biosig Technologies (NASDAQ:STEX) Stock

Biosig Technologies, Inc. (NASDAQ:STEX) CIO Mitchell Young Williams purchased 51,511 shares of the firm’s stock in a transaction on Friday, January 23rd. The stock was acquired at an average cost of $3.03 per share, with a total value of $156,078.33. Following the transaction, the executive directly owned 1,051,511 shares in the company, valued at $3,186,078.33. This trade represents a 5.15% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.

Biosig Technologies Stock Up 6.5%

NASDAQ STEX traded up $0.21 on Monday, hitting $3.46. 1,705,753 shares of the stock were exchanged, compared to its average volume of 1,176,160. Biosig Technologies, Inc. has a fifty-two week low of $0.40 and a fifty-two week high of $14.11. The stock has a market capitalization of $514.19 million, a PE ratio of -2.56 and a beta of 1.48.

Biosig Technologies Company Profile

Biosig Technologies (NASDAQ:STEX) is a medical technology company focused on developing advanced signal acquisition and processing solutions for cardiac electrophysiology. The company’s work centers on improving the clarity and interpretability of intracardiac signals captured during electrophysiology procedures, with the goal of helping clinicians identify arrhythmogenic substrates and make more informed procedural decisions.

Its primary offering is a signal-processing platform that combines proprietary hardware and software to amplify, filter and display intracardiac electrical activity with reduced noise and distortion.